Who
R. Judd Jessup
Director
Company insider
Files Form 4 as: Director, CorVel; President and CEO, CombiMatrix; Director, Novamed.
In numbers
- Trades disclosed
- 345
- Buys
- 0
- Sells
- 58
- Bought
- $0
- Sold
- $11.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 10 Nov 2005
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $282K4,023 at $70.07 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $282K4,023 at $70.07 | filing |
| 27 Aug 2026filed 28 Aug 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $89K1,262 at $70.64 | filing |
| 27 Aug 2026filed 28 Aug 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $89K1,262 at $70.64 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $110K1,562 at $70.71 | filing |
| 26 Aug 2026filed 28 Aug 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $110K1,562 at $70.71 | filing |
| 6 Aug 2026filed 10 Aug 2026 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | CRVL CorVelInsurance | SEC FORM 4 Code M | $130K9,000 at $14.44 | filing |
| 11 Jun 2026filed 12 Jun 2026 | CRVL CorVelInsurance | SEC FORM 4 Code F | $131K2,153 at $60.79 | filing |
| 11 Jun 2026filed 12 Jun 2026 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code M | $547K9,000 at $60.79 | filing |
| 11 Jun 2026filed 12 Jun 2026 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code M | $547K9,000 at $60.79 | filing |
| 11 Jun 2026filed 12 Jun 2026 | CRVL CorVelInsurance | SEC FORM 4 Code M | $130K9,000 at $14.44 | filing |
| 11 Jun 2026filed 12 Jun 2026 | CRVL CorVelInsurance | SEC FORM 4 Code F | $131K2,153 at $60.79 | filing |
| 11 Nov 2025filed 12 Nov 2025 | CRVL CorVelInsurance | SEC FORM 4 Sold | $544K7,076 at $76.94 | filing |
| 10 Nov 2025filed 12 Nov 2025 | CRVL CorVelInsurance | SEC FORM 4 Sold | $16K210 at $76.27 | filing |
| 7 Nov 2025filed 24 Nov 2025 | CRVL CorVelInsurance | SEC FORM 4 Sold | $247K3,247 at $76.20 | filing |
| 7 Aug 2025filed 11 Aug 2025 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | CRVL CorVelInsurance | SEC FORM 4 Sold | $701K6,351 at $110.41 | filing |
| 30 May 2025filed 2 Jun 2025 | CRVL CorVelInsurance | SEC FORM 4 Sold | $17K150 at $111.76 | filing |
News
CorVel (NASDAQ:CRVL) & AdaptHealth (NASDAQ:AHCO) Head-To-Head SurveyCRVL · dailypolitical.com · 24 Oct 2026Comparing InnovAge (NASDAQ:INNV) & CorVel (NASDAQ:CRVL)CRVL · tickerreport.com · 20 Oct 2026Analyzing AdaptHealth (NASDAQ:AHCO) & CorVel (NASDAQ:CRVL)CRVL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name R. Judd Jessup; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.